返回新闻列表
2021年5月10日

The logistics of a pandemic

As the pharmaceutical industry leapt up to meet the challenge of developing a vaccine to combat a global pandemic, its partners in the supply chain had to keep in step. Yann Martin, global sales director of isothermal solutions supplier EMBALL’ISO, tells us how the company ramped up its operations to cope with the surge in demand.
From March 2020, the pharmaceutical industry went into overdrive. Faced with a global pandemic, it had to pivot huge resources into developing diagnostics tests and, ultimately, vaccines to track, trace and prevent the spread of Covid-19. This enormous effort had ramifications throughout the supply chain.

Developing, testing and trailing a new vaccine needed across the globe demanded a huge amount of resources and equipment, and without the right packaging and logistics solutions those efforts would have been held back, with potentially dire consequences.“

From early 2020, there was a huge surge in demand from companies running clinical trials to develop a vaccine, so we needed to supply a lot of equipment to maintain the cold chain on a drastically reduced time frame,” says Yann Martin, global sales director of EMBALL’ISO.“Then, later with vaccine distribution, it was a real challenge to scale up.”

EMBALL’ISO is a market leader in the design and manufacture of high-performance temperature-controlled packaging systems for the transport of pharmaceuticals. Its packaging solutions can maintain stable temperature ranges between -80°C and+37°C, thanks to thermal stabilisers based on gels and phase change material (PCM).

In the 30 years that it has been supporting pharmaceutical laboratories, clinical trial operators, logistics companies and last mile specialists in managing and controlling cold chain risks, the company has never experienced anything on the scale of the Covid-19 pandemic. In mid-2020, it suddenly saw demand skyrocket to more than 30 times the monthly pre-pandemic volume.

“Working under Covid restrictions ourselves, we had to provide the same quality in much larger volumes in a very short time,” remarks Martin. “Fortunately, we have a product design that we can manufacture with equipment selected to be available worldwide and, with eight production centres across the world, we were able to mitigate risks by using different sites when local restrictions changed.”

Reduce, recycle, reuse

Had EMBALL’ISO had one central production facility, its ability to supply a global market would have been at risk.Fortunately, it has a presence on four continents, with production sites in Brazil, China, France, Germany, India, Singapore,the UK and US. That allowed it to handle the huge volume of demand for vaccine trials and distribution while supporting existing clients in other key areas, such as oncology and diagnostics.

Scale and adaptability, however, are not the only strengths that EMBALL’ISO brings to the table. Its innovative packaging design allows not only tight control of temperature ranges throughout the cold chain, but also enables reuse. The company’s reverse logistics capability and a network of collection points in more than 80 countries helps customers to save time and money by reusing its specialist isothermal packaging.

“Our reuse networks have been in operation for a long time,” Martin explains.“The collection and reuse model are very successful because the packaging is not thrown away, which helps to maintain both quality and availability. It also helps us to scale up very fast because we are always monitoring the global flows of our units.”

EMBALL’ISO’s packaging solutions can be used to carry a single vial or can be supplied in fully assembled or flat-packed pallets for larger consignments. The underlying concept is to marry high performance with cost-efficiency and sustainability.“

The lightweight and flat-packable solutions take up less space for reverse and reuse, so there is a reduction in cost and carbon emissions from airfreight shipment and sea freight return,” Martin says. “When the company was started, the underlying concept was to develop the first flat-pack isothermal packaging that would be more compact and easier to dismantle. Very light packaging solutions improve sustainability, which is increasingly a factor of choice in the discussions we have with our clients.”

As well as the virologists and researchers who have worked tirelessly, the successful rollout of Covid-19 vaccines owes much to the versatility and scalability of logistics providers like EMBALL’ISO. 

Please find article in World Pharma here.

其他新闻

2024年10月21日

很荣幸能登上最新一期的《World Pharmaceutical Frontiers》杂志!

在采访中,美洲区销售总监鲍勃·麦克莱恩(Bob McClain)揭示了EMBALL'ISO如何通过我们创新的轻量化、可重复使用的隔热包装解决方案,彻底改变了医药运输。
继续浏览
2024年5月17日

EMBALL'ISO 现已在澳大利亚和新西兰设立子公司!

法国环境友好型医药保温包装生厂商EMBALL’ISO在澳大利亚和新西兰开展业务
继续浏览
2023年9月27日

了解我们将于 2023 年 10 月参加的活动展会列表!

- 2023 年 10 月 4 日至 6 日,我们将参加在波士顿举行的 Logipharma US 展会,展位号为 110。
继续浏览
2023年7月27日

获得"国家卓越奖"的骄傲时刻

EMBALL'ISO印度在7月13日举行的颁奖典礼上荣获"年度最佳温度控制包装设计"的久负盛名的"国家卓越奖"。
继续浏览